Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6113659 | Critical Reviews in Oncology/Hematology | 2014 | 16 Pages |
Abstract
Herein, we review the incidence of amenorrhea and menopause induced by cytotoxic chemotherapy in women affected by early breast cancer and the suggested mechanisms that sustain these side-effects. Furthermore, it has been scrutinized the potential of new markers of ovarian reserve that may facilitate the selection of appropriate endocrine treatment for premenopausal women who develop amenorrhea following adjuvant chemotherapy for early breast cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Francesco Torino, Agnese Barnabei, Liana De Vecchis, Valentina Sini, Francesco Schittulli, Paolo Marchetti, Salvatore Maria Corsello,